References to the "Company," "our," "us" or "we" refer to CF Acquisition Corp.
VIII. The following discussion and analysis of the Company's financial condition
and results of operations should be read in conjunction with the unaudited
condensed financial statements and the notes thereto contained elsewhere in this
report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q (this "Report") includes forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"). We have based these forward-looking statements on our current
expectations and projections about future events. These forward-looking
statements are subject to known and unknown risks, uncertainties and assumptions
about us that may cause our actual results, levels of activity, performance or
achievements to be materially different from any future results, levels of
activity, performance or achievements expressed or implied by such
forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as "may," "should," "could," "would," "expect,"
"plan," "anticipate," "believe," "estimate," "continue," or the negative of such
terms or other similar expressions. Such statements include, but are not limited
to, possible business combinations and the financing thereof, and related
matters, as well as all other statements other than statements of historical
fact included in this Form 10-Q. Factors that might cause or contribute to such
a discrepancy include, but are not limited to, those described in our other
Securities and Exchange Commission ("SEC") filings.
Overview
We are a blank check company incorporated in Delaware on July 8, 2020 for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more
businesses (the "Initial Business Combination"). Our sponsor is CFAC Holdings
VIII, LLC (the "Sponsor").
Although we are not limited in our search for target businesses to a particular
industry or sector for the purpose of consummating the Initial Business
Combination, we are focusing our search on companies operating in the financial
services, healthcare, real estate services, technology and software industries.
We are an early stage and emerging growth company and, as such, we are subject
to all of the risks associated with early stage and emerging growth companies.
Our registration statements for our initial public offering (the "Initial Public
Offering") became effective on March 11, 2021. On March 16, 2021, we consummated
the Initial Public Offering of 25,000,000 units (each, a "Unit" and with respect
to the shares of Class A common stock included in the Units sold, the "Public
Shares"), including 3,000,000 Units sold upon the partial exercise of the
underwriter's over-allotment option, at a purchase price of $10.00 per Unit,
generating gross proceeds of $250,000,000. Each Unit consists of one share of
Class A common stock and one-fourth of one redeemable warrant. Each whole
warrant entitles the holder to purchase one share of Class A common stock at a
price of $11.50. Each warrant will become exercisable 30 days after the
completion of the Initial Business Combination and will expire 5 years after the
completion of the Initial Business Combination, or earlier upon redemption or
liquidation.
Simultaneously with the closing of the Initial Public Offering, we consummated
the sale of 540,000 Units (the "Private Placement Units") at a price of $10.00
per Private Placement Unit to the Sponsor in a private placement (the "Private
Placement"), generating gross proceeds of $5,400,000.
Following the closing of the Initial Public Offering and sale of the Private
Placement Units on March 16, 2021, an amount of $250,000,000 ($10.00 per Unit)
from the net proceeds of the sale of the Units in the Initial Public Offering
and the sale of the Private Placement Units was placed in a trust account (the
"Trust Account") located in the United States at J.P. Morgan Chase Bank, N.A.,
with Continental Stock Transfer & Trust Company acting as trustee, which may be
invested only in U.S. government securities, within the meaning set forth in
Section 2(a)(16) of the Investment Company Act of 1940, as amended (the
"Investment Company Act"), with a maturity of 185 days or less or in any
open-ended investment company that holds itself out as a money market fund
selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of
Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier
of: (i) the completion of an Initial Business Combination and (ii) the
distribution of the Trust Account, as described below.
On March 8, 2022, at a special meeting of our stockholders, our stockholders
approved the extension of our term to complete our Initial Business Combination
from March 16, 2022 to September 30, 2022 (the "First Extension"). In connection
with the First Extension, the Sponsor loaned us an aggregate amount of
$4,424,015 ($0.20 for each Public Share that was not redeemed in connection with
the First Extension) (the "First Extension Loan"). The proceeds of the First
Extension Loan were deposited in the Trust Account on March 9, 2022. The First
Extension Loan will not bear interest and will be repayable by us to the Sponsor
or its designees upon consummation of an Initial Business Combination. In
connection with the stockholder vote to approve the First Extension, 2,879,927
Public Shares were redeemed at $10.00 a share, resulting in a reduction of
$28,799,270 in the amount held in the Trust Account. As a result of the approval
of the First Extension and the First Extension Loan, the amount in the Trust
Account was increased to approximately $10.20 per Public Share.
22
On September 27, 2022, at a special meeting of our stockholders, our
stockholders approved the extension of our term to complete our Initial Business
Combination from September 30, 2022 to March 16, 2023 (the "Second Extension").
In connection with the Second Extension, the Sponsor loaned us an aggregate
amount of $976,832 ($0.33 for each Public Share that was not redeemed in
connection with the Second Extension) (the "Second Extension Loan").
The proceeds of the Second Extension Loan were deposited in the Trust Account on
September 30, 2022. The Second Extension Loan will not bear interest and will be
repayable by us to the Sponsor or its designees upon consummation of an Initial
Business Combination. In connection with the stockholder vote to approve the
Second Extension, 19,159,975 Public Shares were redeemed at approximately $10.23
a share, resulting in a reduction of $196,121,351 in the amount held in the
Trust Account. As a result of the approval of the Second Extension and the
Second Extension Loan, the amount in the Trust Account was increased to
approximately $10.53 per Public Share.
We have until March 16, 2023 or a later date approved by our stockholders in
accordance with the Amended and Restated Certificate of Incorporation, to
consummate an Initial Business Combination (the "Combination Period"). If we are
unable to complete an Initial Business Combination by the end of the Combination
Period, we will (i) cease all operations except for the purpose of winding up,
(ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously
released to us to pay taxes (less up to $100,000 of interest to pay dissolution
expenses), divided by the number of then outstanding Public Shares, which
redemption will completely extinguish public stockholders' rights as
stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law, and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of our remaining stockholders
and our board of directors, dissolve and liquidate, subject in the case of
clauses (ii) and (iii) to our obligations under Delaware law to provide for
claims of creditors and the requirements of other applicable law. There will be
no redemption rights or liquidating distributions with respect to our warrants,
which will expire worthless if we fail to complete an Initial Business
Combination within the Combination Period.
Liquidity and Capital Resources
As of both September 30, 2022 and December 31, 2021, we had approximately
$265,000 and $25,000 of cash in our operating account. As of September 30, 2022
and December 31, 2021, we had a working capital deficit of approximately
$8,825,000 and $2,634,000, respectively. As of September 30, 2022 and December
31, 2021, we had approximately $21,000 and $18,000, respectively, of interest
income from the Trust Account available to pay taxes (less up to $100,000 of
interest to pay dissolution expenses).
Our liquidity needs through September 30, 2022 have been satisfied through a
contribution of $25,000 from the Sponsor in exchange for the issuance of the
founder shares, a loan of approximately $79,000 from the Sponsor pursuant to a
promissory note (the "Pre-IPO Note"), the proceeds from the consummation of the
Private Placement with the Sponsor not held in the Trust Account, the Sponsor
Loan (as defined below) and the First Working Capital Loan (as defined below).
We fully repaid the Pre-IPO Note upon completion of the Initial Public Offering.
In addition, in order to finance transaction costs in connection with an Initial
Business Combination, the Sponsor has committed up to $1,750,000 to be provided
to us to fund our expenses relating to investigating and selecting a target
business and other working capital requirements after the Initial Public
Offering and prior to our Initial Business Combination (the "Sponsor Loan"),
which Sponsor Loan has been fully drawn by us. If the Sponsor Loan is
insufficient, the Sponsor or an affiliate of the Sponsor, or certain of our
officers and directors may, but are not obligated to, provide us additional
loans ("Working Capital Loans").
On June 30, 2022, we entered into a Working Capital Loan with the Sponsor in the
amount of up to $1,000,000 (the "First Working Capital Loan") in connection with
advances the Sponsor will make to us for working capital expenses, which First
Working Capital Loan has been fully drawn by us.
On October 14, 2022, we entered into a second Working Capital Loan with the
Sponsor in the amount of up to $750,000 (the "Second Working Capital Loan") in
connection with advances the Sponsor will make to us for working capital
expenses.
On March 9, 2022, we borrowed $4,424,015 ($0.20 for each Public Share that was
not redeemed in connection with the First Extension) from the Sponsor pursuant
to the First Extension Loan, which was deposited in the Trust Account.
On September 30, 2022, we borrowed $976,832 ($0.33 for each Public Share that
was not redeemed in connection with the Second Extension) from the Sponsor
pursuant to the Second Extension Loan, which was deposited in the Trust Account.
As of September 30, 2022 and December 31, 2021, approximately $8,151,000 and
$734,000, respectively, was outstanding under the loans payable by us to the
Sponsor. As of September 30, 2022 and December 31, 2021, these amounts included
$1,750,000 and approximately $734,000, respectively, outstanding under the
Sponsor Loan, $4,424,015 and $0, respectively, outstanding under the First
Extension Loan, $976,832 and $0, respectively, outstanding under the Second
Extension Loan, and $1,000,000 and $0, respectively, outstanding under the First
Working Capital Loan. See "Related Party Loans" below for additional
information.
Based on the foregoing, management believes that we will have sufficient working
capital and borrowing capacity from the Sponsor to meet our needs through the
earlier of the consummation of an Initial Business Combination or one year from
the date of this report. Over this time period, we will be using these funds for
paying existing accounts payable, identifying and evaluating prospective target
businesses, performing due diligence on prospective target businesses, paying
for travel expenditures, selecting the target business to merge with or acquire,
and structuring, negotiating and consummating the Initial Business Combination.
23
Results of Operations
Our entire activity from inception through September 30, 2022 related to our
formation, the Initial Public Offering, and, to our efforts towards locating and
completing a suitable Initial Business Combination. We have neither engaged in
any operations nor generated any revenues to date. We will not generate any
operating revenues until after completion of our Initial Business Combination.
We will generate non-operating income in the form of interest income on
investments held in the Trust Account. We expect to incur increased expenses as
a result of being a public company (for legal, financial reporting, accounting
and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had a net loss of
approximately $811,000 which consisted of approximately $1,109,000 of general
and administrative expenses, approximately $690,000 of interest expense due to
the redemption of Class A common stock, approximately $456,000 of loss from the
change in fair value of FPS liability, approximately $98,000 of income tax
expense, $50,000 of franchise tax expense, and $30,000 of administrative
expenses paid to the Sponsor, partially offset by approximately $1,103,000 of
gain from the change in fair value of warrant liability and approximately
$519,000 of interest income on investments held in the Trust Account.
For the nine months ended September 30, 2022, we had net income of approximately
$3,566,000 which consisted of approximately $4,726,000 of gain from the change
in fair value of warrant liability, approximately $957,000 of interest income on
investments held in the Trust Account, approximately $579,000 of other income
and approximately $249,000 of gain from the change in fair value of FPS
liability, partially offset by approximately $1,913,000 of general and
administrative expenses, approximately $690,000 of interest expense due to the
redemption of Class A common stock, approximately $139,000 of income tax
expense, approximately $113,000 of franchise tax expense and $90,000 of
administrative expenses paid to the Sponsor.
For the three months ended September 30, 2021, we had a net loss of
approximately $1,055,000, which consisted of approximately $1,137,000 in general
and administrative expenses, $60,000 of franchise tax expense and $30,000 in
administrative expenses paid to the Sponsor, which were partially offset by
approximately $102,000 of gain from change in fair value of the FPS liability,
approximately $64,000 of gain from the change in fair value of the warrant
liability, and approximately $6,000 in interest income on investments held in
Trust Account.
For the nine months ended September 30, 2021, we had a net loss of approximately
$2,441,000, which consisted of approximately $2,001,000 of loss from the change
in fair value of the FPS liability, approximately $1,539,000 in general and
administrative expenses, approximately $141,000 of franchise tax expense, and
approximately $65,000 in administrative expenses paid to the Sponsor, which were
partially offset by approximately $1,294,000 of gain from the change in fair
value of warrants liability and approximately $11,000 in interest income on
investments held in the Trust Account.
Contractual Obligations
Business Combination Marketing Agreement
We engaged Cantor Fitzgerald & Co. ("CF&Co."), an affiliate of the Sponsor, as
an advisor in connection with the Initial Business Combination to assist us in
holding meetings with our stockholders to discuss any potential Initial Business
Combination and the target business' attributes, introduce us to potential
investors that are interested in purchasing our securities and assist us with
our press releases and public filings in connection with any Initial Business
Combination. We will pay CF&Co. a cash fee for such services upon the
consummation of the Initial Business Combination in an amount of $9,350,000 (the
"Marketing Fee"), which is equal to, in the aggregate, 3.5% of the gross
proceeds of the base offering in the Initial Public Offering and 5.5% of the
gross proceeds from the partial exercise of the underwriters' over-allotment
option; provided, however, in connection with the proposed business combination
between us and XBP Europe, Inc. ("XBP Europe"), as described in Note 9 -
"Subsequent events" to our unaudited condensed financial statements in Part I,
Item 1 of this report, subject to and conditioned upon the closing of such
business combination, CF&Co. agreed to waive the Marketing Fee. In addition, we
engaged CF&Co. as our exclusive financial advisor for the proposed business
combination with XBP Europe, but CF&Co. is not entitled to any fee with respect
to such engagement.
24
Related Party Loans
In order to finance transaction costs in connection with an intended Initial
Business Combination, the Sponsor committed up to $1,750,000 in the Sponsor Loan
to be provided to us to fund expenses relating to investigating and selecting a
target business and other working capital requirements, including $10,000 per
month for office space, administrative and shared personnel support services
that will be paid to the Sponsor, after the Initial Public Offering and prior to
the Initial Business Combination, which has been fully drawn by us.
On March 9, 2022, we borrowed $4,424,015 ($0.20 for each Public Share that was
not redeemed in connection with the First Extension) from the Sponsor pursuant
to the First Extension Loan, which was deposited in the Trust Account. The First
Extension Loan will not bear interest and will be repayable by us to the Sponsor
or its designees upon consummation of an Initial Business Combination.
On September 30, 2022, we borrowed $976,832 ($0.33 for each Public Share that
was not redeemed in connection with the Second Extension) from the Sponsor
pursuant to the Second Extension Loan, which was deposited in the Trust Account.
The Second Extension Loan will not bear interest and will be repayable by us to
the Sponsor or its designees upon consummation of an Initial Business
Combination.
On June 30, 2022, we entered into the First Working Capital Loan, which has been
fully drawn by us. The First Working Capital Loan bears no interest and is due
and payable on the date on which we consummate our Initial Business Combination.
The principal balance of the First Working Capital Loan may be prepaid at any
time.
On October 14, 2022, we entered into the Second Working Capital Loan. The Second
Working Capital Loan bears no interest and is due and payable on the date on
which we consummate our Initial Business Combination. The principal balance of
the Second Working Capital Loan may be prepaid at any time.
As of September 30, 2022 and December 31, 2021, approximately $8,151,000 and
$734,000, respectively, was outstanding under the loans payable by us to the
Sponsor. As of September 30, 2022 and December 31, 2021, these amounts included
$1,750,000 and approximately $734,000, respectively, outstanding under the
Sponsor Loan, $4,424,015 and $0, respectively, outstanding under the First
Extension Loan, $976,832 and $0, respectively, outstanding under the Second
Extension Loan, and $1,000,000 and $0, respectively, outstanding under the First
Working Capital Loan.
The Sponsor pays expenses on our behalf and we reimburse the Sponsor for such
expenses paid on our behalf. As of September 30, 2022 and December 31, 2021, we
had accounts payable outstanding to the Sponsor for such expenses paid on our
behalf of approximately $78,000 and $571,000, respectively.
Further, in connection with the proposed business combination with XBP Europe,
subject to and conditioned upon the closing of such business combination, the
Sponsor agreed that all amounts outstanding under loans from the Sponsor to us
shall be automatically converted into shares of Class A common stock in
accordance with, and subject to the exceptions set forth in, the Agreement and
Plan of Merger, dated October 9, 2022, among us, XBP Europe and the other
parties thereto.
Critical Accounting Policies and Estimates
We have identified the following as our critical accounting polices:
Use of Estimates
The preparation of our unaudited condensed financial statements and related
disclosures in conformity with U.S. GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities,
income and expenses, and the disclosure of contingent assets and liabilities in
our unaudited condensed financial statements. These accounting estimates require
the use of assumptions about matters, some of which are highly uncertain at the
time of estimation. Management bases its estimates on historical experience and
on various other assumptions it believes to be reasonable under the
circumstances, the results of which form the basis for making judgments, and we
evaluate these estimates on an ongoing basis. To the extent actual experience
differs from the assumptions used, our unaudited condensed balance sheets,
unaudited condensed statements of operations, unaudited condensed statements of
stockholders' deficit and unaudited condensed statements of cash flows could be
materially affected. We believe that the following accounting policies involve a
higher degree of judgment and complexity.
25
Going Concern
In connection with our going concern considerations in accordance with guidance
in the Financial Accounting Standards Board Accounting Standards Codification
("ASC") 205-40, Presentation of Financial Statements - Going Concern, we have
until March 16, 2023 to consummate an Initial Business Combination. Our
mandatory liquidation date, if an Initial Business Combination is not
consummated, raises substantial doubt about our ability to continue as a going
concern. Our unaudited condensed financial statements included in this Report do
not include any adjustments related to the recovery of the recorded assets or
the classification of the liabilities should we be unable to continue as a going
concern. In the event of a mandatory liquidation, within ten business days, we
will redeem the Public Shares, at a per-share price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Account including interest
earned on the funds held in the Trust Account and not previously released to us
to pay taxes (less up to $100,000 of interest to pay dissolution expenses),
divided by the number of then outstanding Public Shares.
Emerging Growth Company
Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the "JOBS
Act") exempts emerging growth companies from being required to comply with new
or revised financial accounting standards until private companies (that is,
those that have not had a registration statement under the Securities Act of
1933, as amended (the "Securities Act") declared effective or do not have a
class of securities registered under the Exchange Act) are required to comply
with the new or revised financial accounting standards. The JOBS Act provides
that a company can elect to opt out of the extended transition period and comply
with the requirements that apply to non-emerging growth companies but any such
election to opt out is irrevocable. We have elected not to opt out of such
extended transition period which means that when a standard is issued or revised
and it has different application dates for public or private companies, we, as
an emerging growth company, can adopt the new or revised standard at the time
private companies adopt the new or revised standard.
Warrant and FPS Liability
We account for our outstanding public warrants and private placement warrants
and the securities underlying the forward purchase agreement with the Sponsor
(the "FPA" and such securities, the "FPS") in accordance with guidance in ASC
815-40, Derivatives and Hedging - Contracts in Entity's Own Equity, under which
the warrants and the FPS do not meet the criteria for equity classification and
must be recorded as liabilities. As both the public and private placement
warrants and the FPS meet the definition of a derivative under ASC 815,
Derivatives and Hedging, they are measured at fair value at inception and at
each reporting date in accordance with the guidance in ASC 820, Fair Value
Measurement, with any subsequent changes in fair value recognized in the
statement of operations in the period of change.
Class A Common Stock Subject to Possible Redemption
We account for our Class A common stock subject to possible redemption in
accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity.
Shares of Class A common stock subject to mandatory redemption (if any) are
classified as liability instruments and measured at fair value. Shares of
conditionally redeemable Class A common stock (including shares of Class A
common stock that feature redemption rights that are either within the control
of the holder or subject to redemption upon the occurrence of uncertain events
not solely within our control) are classified as temporary equity. At all other
times, shares of Class A common stock are classified as stockholders' equity.
All of the Public Shares feature certain redemption rights that are considered
to be outside of our control and subject to the occurrence of uncertain future
events. Accordingly, as of September 30, 2022 and December 31, 2021, 2,960,098
and 25,000,000 shares of Class A common stock subject to possible redemption,
respectively, are presented as temporary equity outside of the stockholders'
deficit section of our balance sheets. We recognize any subsequent changes in
redemption value immediately as they occur and adjust the carrying value of
redeemable shares of Class A common stock to the redemption value at the end of
each reporting period. Immediately upon the closing of the Initial Public
Offering, we recognized the accretion from initial book value to redemption
amount value of redeemable Class A common stock. This method would view the end
of the reporting period as if it were also the redemption date for the security.
The change in the carrying value of redeemable shares of Class A common stock
also resulted in charges against Additional paid-in capital and Accumulated
deficit.
Net Income (Loss) Per Share of Common Stock
We comply with the accounting and disclosure requirements of ASC 260, Earnings
Per Share. Net income (loss) per share of common stock is computed by dividing
net income (loss) applicable to stockholders by the weighted average number of
shares of common stock outstanding for the applicable periods. We apply the
two-class method in calculating earnings per share and allocate net income
(loss) pro-rata to shares of Class A common stock subject to possible
redemption, nonredeemable shares of Class A common stock and shares of Class B
common stock. Accretion associated with the redeemable shares of Class A common
stock is excluded from earnings per share as the redemption value approximates
fair value.
26
We have not considered the effect of the warrants to purchase an aggregate of
6,385,000 shares of Class A common stock sold in the Initial Public Offering and
the concurrent Private Placement in the calculation of diluted earnings per
share, because their exercise is contingent upon future events and their
inclusion would be anti-dilutive under the treasury stock method. As a result,
diluted earnings per share of common stock is the same as basic earnings per
share of common stock for the periods presented.
See Note 2- "Summary of Significant Accounting Policies" to our unaudited
condensed financial statements in Part I, Item 1 of this report for additional
information regarding these critical accounting policies and other significant
accounting policies.
Factors That May Adversely Affect Our Results of Operations
Our results of operations and our ability to complete an Initial Business
Combination may be adversely affected by various factors that could cause
economic uncertainty and volatility in the financial markets, many of which are
beyond our control. Our business could be impacted by, among other things,
downturns in the financial markets or in economic conditions, increases in oil
prices, inflation, increases in interest rates, supply chain disruptions,
declines in consumer confidence and spending, the ongoing effects of the
COVID-19 pandemic, including resurgences and the emergence of new variants, and
geopolitical instability, such as the military conflict in the Ukraine. We
cannot at this time fully predict the likelihood of one or more of the above
events, their duration or magnitude or the extent to which they may negatively
impact our business and our ability to complete an Initial Business
Combination.
Off-Balance Sheet Arrangements and Contractual Obligations
As of September 30, 2022, we did not have any off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments
or contractual obligations.
© Edgar Online, source Glimpses